The Relative Safety of Ephedra Compared with Other Herbal Products [4]

Annals of Internal Medicine

Volumn 139, Issue 3, 2003, Pages 234-

  Kimmel, Stephen E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRA EXTRACT; HERBACEOUS AGENT;

DRUG SAFETY; HUMAN; LETTER; PRIORITY JOURNAL; SIDE EFFECT; EPHEDRA; NOTE; PHYTOTHERAPY; PLANT; RISK; SAFETY;

EPHEDRA; HUMANS; PHYTOTHERAPY; PLANT COMPONENTS; RISK; SAFETY;

EID: 1642576122     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-3-200308050-00020     Document Type: Letter

References (3)

1. Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003;138:468-71. [PMID: 12639079]
2. Kimmel SE. Summary of incidence of seizures, strokes, and myocardial infarctions in the population and estimations of risk in the population from ephedra products. Presented at the Department of Health and Human Services Public Meeting on the Safety of Dietary Supplements Containing Ephedrine Alkaloids, August 2000. Submitted to the U.S. Food and Drug Administration Docket No. 00N-1200. Washington, DC: Ephedra Education Council; 2002. Accessed at www.ephedrafacts.com/ 2.html on 25 June 2003.
3. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289:1537-45. [PMID: 12672771]